全文获取类型
收费全文 | 31014篇 |
免费 | 1510篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 395篇 |
儿科学 | 2231篇 |
妇产科学 | 676篇 |
基础医学 | 3437篇 |
口腔科学 | 556篇 |
临床医学 | 1829篇 |
内科学 | 5867篇 |
皮肤病学 | 1149篇 |
神经病学 | 1547篇 |
特种医学 | 1102篇 |
外科学 | 4739篇 |
综合类 | 1015篇 |
一般理论 | 10篇 |
预防医学 | 1480篇 |
眼科学 | 1575篇 |
药学 | 2580篇 |
2篇 | |
中国医学 | 169篇 |
肿瘤学 | 2243篇 |
出版年
2023年 | 200篇 |
2022年 | 490篇 |
2021年 | 934篇 |
2020年 | 523篇 |
2019年 | 595篇 |
2018年 | 824篇 |
2017年 | 556篇 |
2016年 | 804篇 |
2015年 | 754篇 |
2014年 | 1152篇 |
2013年 | 1408篇 |
2012年 | 1991篇 |
2011年 | 2099篇 |
2010年 | 1131篇 |
2009年 | 931篇 |
2008年 | 1568篇 |
2007年 | 1669篇 |
2006年 | 1454篇 |
2005年 | 1355篇 |
2004年 | 1242篇 |
2003年 | 1096篇 |
2002年 | 948篇 |
2001年 | 756篇 |
2000年 | 712篇 |
1999年 | 621篇 |
1998年 | 266篇 |
1997年 | 205篇 |
1996年 | 161篇 |
1995年 | 154篇 |
1994年 | 129篇 |
1993年 | 146篇 |
1992年 | 360篇 |
1991年 | 395篇 |
1990年 | 352篇 |
1989年 | 365篇 |
1988年 | 312篇 |
1987年 | 282篇 |
1986年 | 269篇 |
1985年 | 284篇 |
1984年 | 220篇 |
1983年 | 182篇 |
1979年 | 241篇 |
1978年 | 158篇 |
1977年 | 148篇 |
1976年 | 135篇 |
1975年 | 163篇 |
1974年 | 154篇 |
1973年 | 176篇 |
1972年 | 138篇 |
1971年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
72.
73.
74.
Harshit Garg Sandeep Aggarwal Rajni Yadav Siddhartha Datta Gupta Lokesh Agarwal Samagra Agarwal 《Surgery for obesity and related diseases》2018,14(1):81-91
Background
Controlled attenuation parameter (CAP) is a novel, noninvasive technique for assessing hepatic steatosis. However, its role in morbidly obese individuals is unclear. The effect of bariatric surgery on inflammation and fibrosis needs to be explored.Objectives
To assess the utility of CAP for assessment of hepatic steatosis in morbidly obese individuals and evaluate the effect of bariatric surgery on hepatic steatosis and fibrosis.Setting
A tertiary care academic hospital.Methods
Baseline details of anthropometric data, laboratory parameters, FibroScan (XL probe), and liver biopsy were collected. Follow-up liver biopsy was done at 1 year.Results
Of the 124 patients screened, 76 patients were included; mean body mass index was 45.2 ± 7.1 kg/m2. FibroScan success rate was 87.9%. The median liver stiffness measurement (LSM) and CAP were 7.0 (5.0–9.5) kPa and 326.5 (301–360.5) dB/m, respectively. On liver histopathology, severe steatosis and nonalcoholic steatohepatitis were present in 5.3% and 15.8%; significant fibrosis (≥stage 2) and cirrhosis in 39.5% and 2.6%, respectively. Area under receiver operator characteristic curve of LSM for prediction of significant fibrosis (F2–4 versus F0–1) and advanced fibrosis (F3–4 versus F0–2) was .65 (95% confidence interval [CI]: .52–.77) and .83 (95% CI: .72–.94), respectively. The area under receiver operator characteristic curve of CAP for differentiating moderate hepatic steatosis (S2–3 versus S0–1) and severe hepatic steatosis (S3 versus S0–2) was .74 (95% CI: .62–.86) and .82 (95% CI: .73–.91), respectively. At 1-year follow-up, 32 patients underwent liver biopsy. In these patients, there was significant improvement in hepatic steatosis (P = .001), lobular inflammation (P = .033), ballooning (P<.001), and fibrosis (P = .003). Nonalcoholic steatohepatitis was resolved in 3 of 4 (75%) patients. LSM and CAP significantly declined.Conclusions
LSM and CAP are feasible and accurate at diagnosing advanced fibrosis and severe hepatic steatosis in morbidly obese individuals. Bariatric surgery is associated with significant improvement in LSM, CAP, steatohepatitis, and fibrosis. 相似文献75.
Emma Rose McGlone Ajay K. Gupta Marcus Reddy Omar A. Khan 《Surgery for obesity and related diseases》2018,14(6):857-864
Although laparoscopic sleeve gastrectomy is an established operation for severe obesity, there is controversy regarding the extent to which the antrum is excised. The objective of this systematic review was to investigate the effect on perioperative complications and medium-term outcomes of antral resecting versus antral preserving sleeve gastrectomy. MEDLINE, EMBASE, and Cochrane databases were searched from 1946 to April 2017. Eligible studies compared antral resection (staple line commencing 2–3 cm from pylorus) with antral preservation (>5 cm from pylorus) in patients undergoing primary sleeve gastrectomy for obesity. Meta-analyses were performed with a random-effects model, and risk of bias within and across studies was assessed using validated scoring systems. Eight studies (619 participants) were included: 6 randomized controlled trials and 2 cohort studies. Overall follow-up was 94% for the specified outcomes of each study. Mean percentage excess weight loss was 62% at 12 months (7 studies; 574 patients) and 67% at 24 months (4 studies; 412 patients). Antral resection was associated with significant improvement in percentage excess weight loss at 24-month follow-up (mean 70% versus 61%; standardized mean difference .95; confidence interval .35–1.58, P<.005), an effect that remained significant when cohort studies were excluded. There was no difference in incidence of perioperative bleeding, leak, or de novo gastroesophageal reflux disease. According to the available evidence, antral resection is associated with better medium-term weight loss compared with antral preservation, without increased risk of surgical complications. Further randomized clinical trials are indicated to confirm this finding. 相似文献
76.
Liver transplantation (LT) is the gold standard for end-stage liver disease (Prince Postgrad Med J 78:135–141, 2002). LT is a technically demanding operation. It needs experienced surgical team along with good anesthesia and critical care support (David et al. Gastroenterol Clin North Am 17:1–18, 1988). Survival after LT is approximately 90% at 1 year. Unlike other organs, 1 and 10-year survival for liver transplantation are the same (Jain and Reyes Ann Surg 232(4):490–500, 2000). Complications after LT are classified into technical, infective, and immunological (Moon and Lee Gut Liver 3(3):145–165, 2009). Re-exploratory laparotomy (REL) is one of the surgical complications of LT. Our study was aimed at analyzing the indications and impact of REL on the patient outcomes after living donor liver transplantation in our center. Retrospective analysis of all LTs done at our center by the same surgical team from January 1 2011 to June 30 2016 was included in the study. Pediatric transplants, combined liver kidney transplants, cadaveric transplants, planned REL, and re-transplantations were excluded from the study. Re-explored patients (REL) were classified as study group, and non-re-explored (NREL) patients were used as controls for statistical comparison. Twenty-five parameters (preoperative, intraoperative, and postoperative) between the two groups were studied. SPSS 22 statistical software was used for statistical analysis. The total number of LT during the study period was 1352. After exclusion, 1241 patients were in the study group. REL group had 111 patients. Out of 111 patients, 97 had one REL, 13 patients had two RELs, and 1 had three RELs. Hence, there were 126 RELs in 111 patients. NREL group had 1140 patients. REL rate in our series was 10.02%. On univariate analysis of 25 parameters analyzed between the two groups, age, graft weight, multiple bile ducts, and mortality were found to be statistically significant (P < 0.05). Preoperative total leucocyte count, model for end-stage liver disease, and warm ischemia time were statistically significant (P < 0.1). On subgroup analysis of REL, bleeding was the commonest indication followed by intraabdominal sepsis. Delayed non-function and small for size had high mortality rates. Multiple RELs were associated with higher mortality compared to single REL (P < 0.05). REL is associated with poor prognosis after adult living donor liver transplantation. 相似文献
77.
78.
79.
80.